Maternal Mental Health Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease Indication (Postpartum Depression, Dysthymia, Pregnancy and Postpartum General Anxiety, Pregnancy and Postpartum OCD, Birth-Related PTSD, Others), By Therapy (Interpersonal Psychotherapy, Antidepressants, Cognitive Behavioral Therapy, others), By Region & Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 5.97 Billion
CAGR (2026-2031)	9.99%
Fastest Growing Segment	Antidepressants
Largest Market	North America
Market Size (2031)	USD 10.57 Billion

Market Overview

The Global Maternal Mental Health Market is projected to grow from USD 5.97 Billion in 2025 to USD 10.57 Billion by 2031 at a 9.99% CAGR. The global maternal mental health market encompasses a diverse range of diagnostic tools, therapeutic interventions, and support services aimed at preventing, identifying, and treating mental health conditions during pregnancy and the postpartum period. Key drivers supporting market expansion include increasing public and professional awareness of perinatal mental health disorders, a growing understanding of the profound impact maternal well-being has on child development, and the rising prevalence of conditions such as postpartum depression and anxiety globally. According to the World Health Organization, in 2023, approximately 10% of pregnant women and 13% of women who have just given birth globally experience a mental disorder, primarily depression.

A significant challenge that could impede market growth is the persistent global scarcity of specialized maternal mental health professionals, particularly in underserved regions. This lack of adequate human resources restricts access to timely and appropriate care, potentially limiting the adoption and scaling of necessary interventions and services within the market.

Key Market Drivers

Government funding and supportive policies are significantly bolstering the global maternal mental health market by creating dedicated infrastructure and improving service accessibility. These governmental initiatives often translate into direct financial investment, enabling the expansion of essential care pathways. For instance, according to the Royal College of Midwives, in February 2025, £36.5 million was allocated to improve mental health support for families in England as part of a £126 million government funding boost for 2025 to 2026. Such financial commitments allow for the development and scaling of specialized perinatal mental health services, training of professionals, and implementation of screening programs. Policies also drive market growth by mandating insurance coverage and promoting integrated care models, which ensure that maternal mental health services become a recognized and reimbursed component of overall maternal care.

Advancements in digital and telehealth mental healthcare delivery are another potent driver, transforming how maternal mental health services are accessed, particularly in underserved areas. These technological innovations, including mobile applications, virtual therapy platforms, and remote monitoring tools, directly address geographical barriers and resource shortages, making timely support more feasible. According to the "2026 Mental Health Technology Map" by Startup Nation Central, released in January 2026, investment in the broader mental health technology sector surged to $352 million in 2025, representing a 150% increase from the previous year, which reflects a growing focus on scalable solutions applicable to maternal mental health. This influx of capital supports the development of user-friendly and effective digital solutions, enhancing convenience and reducing stigma by allowing discreet access to care. Such innovation is crucial, especially as, according to a session at Benefits Canada's 2025 Mental Health Summit, in August 2025, the annual economic cost of untreated maternal mental health conditions in Canada is estimated at $11 billion.

Download Free Sample Report

Key Market Challenges

The persistent global scarcity of specialized maternal mental health professionals represents a significant impediment to the growth of the global maternal mental health market. This shortage directly restricts access to timely and appropriate care, limiting the widespread adoption and scaling of necessary diagnostic tools, therapeutic interventions, and support services. The market's expansion is hindered as a substantial portion of the population requiring these services cannot readily obtain them due to an insufficient workforce.

This lack of adequate human resources creates substantial service gaps. According to the Policy Center for Maternal Mental Health, in 2025, 84% of the perinatal population in the United States still resided in maternal mental health provider shortage areas. Such widespread shortages underscore how limitations in professional availability directly suppress market penetration and the overall delivery of care, thereby constraining revenue potential and the reach of critical interventions designed to address perinatal mental health disorders.

Key Market Trends

The emergence and adoption of digital therapeutics (DTx) significantly influence the global maternal mental health market by offering scalable, evidence-based interventions. These software-driven solutions provide therapeutic programs for conditions like postpartum depression, enhancing accessibility for individuals facing barriers to traditional care. Market growth is driven by regulatory support and the development of clear reimbursement pathways. According to "Are Maternal Mental Health Digital Therapeutics Ready for Prime Time?" published in December 2024, the Centers for Medicare and Medicaid Services (CMS) introduced three new Healthcare Common Procedure Coding System billing codes in its Proposed 2025 Medicare Physician Fee Schedule, effective January 1, 2025, specifically for FDA-cleared digital mental health treatment devices. This establishes a framework for reimbursement, encouraging broader market adoption.

The increased integration of behavioral health services within obstetric settings represents another pivotal trend reshaping the maternal mental health market. This approach embeds mental health screening, assessment, and treatment directly into prenatal and postpartum care, facilitating earlier detection and intervention. Such integration helps overcome care fragmentation and reduces access barriers, making mental health support a routine component of maternal healthcare. According to the Policy Center for Maternal Mental Health's "2025 Impact Report," released in January 2026, an analysis of 41 state Medicaid Managed Care Organization contracts revealed that only nine states required or incentivized obstetric providers to address maternal mental health through screening, reimbursement, or HEDIS® reporting. This indicates a nascent but growing regulatory push toward more comprehensive, integrated care models.

Segmental Insights

The Antidepressants segment is experiencing rapid growth within the Global Maternal Mental Health Market, primarily driven by a significant increase in awareness and early screening initiatives for maternal mental health conditions. Growing recognition of conditions such as postpartum depression and perinatal anxiety has led to a greater propensity for diagnosis and subsequent pharmacological intervention. Advancements in novel antidepressant therapies, including neurosteroid-based treatments, contribute to enhanced efficacy and safety, influencing prescribing trends. Furthermore, evolving clinical guidelines from professional organizations increasingly support the use of antidepressants for perinatal mood and anxiety disorders, expanding treatment uptake and accessibility due to fewer barriers compared to other therapies.

Regional Insights

North America dominates the global maternal mental health market due to its advanced healthcare infrastructure, which provides extensive access to mental health services. The region benefits from high public awareness of maternal mental health conditions, leading to earlier diagnosis and increased engagement in health-seeking behaviors among expectant and new mothers. Furthermore, supportive government initiatives and substantial funding contribute significantly to market expansion. For instance, the U.S. Department of Health and Human Services, through agencies like the Health Resources and Services Administration, has implemented programs such as the Maternal Mental Health Hotline and expanded Medicaid coverage, thereby enhancing access to critical maternal mental healthcare services. These elements collectively solidify North America's leading position.

Recent Developments

• In December 2025, Babyscripts was recognized for its virtual maternity care solution, actively delivering a comprehensive program that empowers pregnant and postpartum patients. The company's mobile application and integrated care management support provided users with access to essential tools, educational resources, and personalized information tailored to their individual needs. This digital health platform enabled patients to self-identify various clinical and social risk factors through surveys and remote monitoring, ensuring timely interventions and support from care teams. Babyscripts’ ongoing provision of this solution marked a notable advancement in leveraging technology for improved maternal mental health outcomes.
• In November 2025, FamilyWell Health, an integrated women's mental health platform, successfully closed an $8 million Series A funding round. This capital infusion was earmarked for the strategic expansion of its services, specifically targeting perimenopause and menopause care while maintaining its specialization in postpartum support. The company's model focuses on embedding digital coaching and contextual teletherapy into existing health system workflows, aiming to address anxiety, depression, and insomnia for women across their reproductive lifecycles. This funding facilitated the broadening of FamilyWell Health's comprehensive approach to women's mental healthcare, including crucial maternal mental health provisions.
• In September 2025, Seven Starling, a virtual women's behavioral health provider, secured $8 million in funding to accelerate its national expansion across the United States. This investment aimed to broaden the reach of its specialized platform, which focuses on delivering mental health support during key stages including fertility, pregnancy, postpartum, and early parenthood. The company's strategy involved increasing its operational presence from 18 states to over 30 states by the close of 2026, enhancing access to critical care for women experiencing mental health challenges during these vulnerable periods. This expansion represented a significant development in making specialized maternal mental health services more widely available.
• In June 2025, UnitedHealthcare undertook an expansion of its behavioral health network, alongside an active investment in recruiting and training care professionals. This strategic initiative was directly relevant to the global maternal mental health market, as the company aimed to improve access to culturally responsive mental health support for new mothers. The expansion reflected a commitment to addressing the critical needs identified in contemporary maternal mental health research, which highlighted ongoing challenges and the importance of accessible behavioral health services throughout the maternal journey. This effort bolstered the availability of mental health resources for pregnant and postpartum individuals.

Key Market Players

• Therapy Mama
• Canopie Inc
• Pfizer Inc
• Viatris Inc.
• GSK plc
• Alembic Pharmaceuticals Limited
• Keenova Therapeutics plc
• Saphire, Inc.
• Bausch Health Companies Inc.
• Magellan Health, Inc.

By Disease Indication	By Therapy	By Region
Postpartum Depression Dysthymia Pregnancy and Postpartum General Anxiety Pregnancy and Postpartum OCD Birth-Related PTSD Others	Interpersonal Psychotherapy Antidepressants Cognitive Behavioral Therapy others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Maternal Mental Health Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Maternal Mental Health Market, By Disease Indication:

• Postpartum Depression
• Dysthymia
• Pregnancy and Postpartum General Anxiety
• Pregnancy and Postpartum OCD
• Birth-Related PTSD
• Others

• Maternal Mental Health Market, By Therapy:

• Interpersonal Psychotherapy
• Antidepressants
• Cognitive Behavioral Therapy
• others

• Maternal Mental Health Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE